David W. Gryska, Director at PDL BIOPHARMA, INC. (PDLI), sold 150,000 shares at $2.40 ($360K) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Open-market sale of $360k PDLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.40 | 100,000 | $240K | 66.8% |
| 2 | $2.39 | 50,000 | $120K | 33.2% |
| Total | $2.40 avg | 150,000 | $360K | 100% |
| Filing → |
| SGEN | SELL | 2022-11-15 | $968K | — | Filing → |
| SGEN | SELL | 2022-04-21 | $1.2M | — | Filing → |
| SGEN | SELL | 2022-02-09 | $1.1M | — | Filing → |